Results 71 to 80 of about 7,507,788 (276)

A Review on Fault Current Limiting Devices to Enhance the Fault Ride-Through Capability of the Doubly-Fed Induction Generator Based Wind Turbine

open access: yesApplied Sciences, 2018
The doubly-fed induction generator has significant features compared to the fixed speed wind turbine, which has popularised its application in power systems.
Seyed Behzad Naderi   +4 more
doaj   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

Multifaceted Functionalities of Bridge-Type DC Reactor Fault Current Limiters: An Experimentally Validated Investigation

open access: yesEnergies
With the ongoing expansion and interconnection of electrical power systems, alongside the rapid proliferation of renewable distributed generations (DGs), the short-circuit extent in the power grid is experiencing a significant rise.
Behzad Behdani   +4 more
doaj   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Study on Recovery Time of Conduction-Cooled Resistive Superconducting Fault Current Limiter

open access: yesEnergies
This paper presents the influence of superconducting tape insulation on the recovery time of superconducting fault current limiters. The analysis is based on the experimental results of short-circuit tests.
Janusz Kozak
doaj   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

Corless Inductive Superconducting Fault Current Limiters [PDF]

open access: yes, 2018
Siły elektrodynamiczne występujące w trakcie przepływu prądu zwarciowego mogą uszkodzić urządzenia systemu elektroenergetycznego w ciągu kilkudziesięciu milisekund.
Majka, M.
core   +1 more source

Fault Ride-through Capability Enhancement of Voltage Source Converter-High Voltage Direct Current Systems with Bridge Type Fault Current Limiters

open access: yesEnergies, 2017
This paper proposes the use of bridge type fault current limiters (BFCLs) as a potential solution to reduce the impact of fault disturbance on voltage source converter-based high voltage DC (VSC-HVDC) systems.
Md Shafiul Alam   +1 more
doaj   +1 more source

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

open access: yesMolecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy